BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15529146)

  • 1. The Cartagena protocol and GMOs.
    Pythoud F
    Nat Biotechnol; 2004 Nov; 22(11):1347-8. PubMed ID: 15529146
    [No Abstract]   [Full Text] [Related]  

  • 2. Putting Cartagena into practice.
    Watanabe KN; Taeb M; Okusu H
    Nat Biotechnol; 2004 Oct; 22(10):1207-8. PubMed ID: 15470448
    [No Abstract]   [Full Text] [Related]  

  • 3. Recipe for disaster.
    Nat Biotechnol; 2003 May; 21(5):465. PubMed ID: 12721554
    [No Abstract]   [Full Text] [Related]  

  • 4. Italy employs further GMO delay tactics.
    Meldolesi A
    Nat Biotechnol; 2003 Apr; 21(4):346. PubMed ID: 12665808
    [No Abstract]   [Full Text] [Related]  

  • 5. The Cartagena Protocol and the future of agbiotech.
    De Greef W
    Nat Biotechnol; 2004 Jul; 22(7):811-2. PubMed ID: 15229537
    [No Abstract]   [Full Text] [Related]  

  • 6. Agriculture is biotechnology's future in Europe.
    Burke JF; Thomas SM
    Nat Biotechnol; 1997 Aug; 15(8):695-6. PubMed ID: 9255772
    [No Abstract]   [Full Text] [Related]  

  • 7. Agbiotech climbs Africa's agenda.
    Fox JL
    Nat Biotechnol; 2003 Jun; 21(6):589. PubMed ID: 12776132
    [No Abstract]   [Full Text] [Related]  

  • 8. USDA scrutinizes GM organism regulations.
    Fox JL
    Nat Biotechnol; 2004 Mar; 22(3):254-5. PubMed ID: 14990936
    [No Abstract]   [Full Text] [Related]  

  • 9. The science and politics of plant biotechnology--a personal perspective.
    Vasil IK
    Nat Biotechnol; 2003 Aug; 21(8):849-51. PubMed ID: 12894193
    [No Abstract]   [Full Text] [Related]  

  • 10. A model protocol to assess the risks of agricultural introductions.
    Barton J; Crandon J; Kennedy D; Miller H
    Nat Biotechnol; 1997 Sep; 15(9):845-8. PubMed ID: 9306396
    [No Abstract]   [Full Text] [Related]  

  • 11. EU plans to label and trace GMOs.
    Dorey E
    Nat Biotechnol; 2001 Sep; 19(9):795. PubMed ID: 11533623
    [No Abstract]   [Full Text] [Related]  

  • 12. When biotech crosses borders.
    Angulo E; Gilna B
    Nat Biotechnol; 2008 Mar; 26(3):277-82. PubMed ID: 18327233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biotechnology revolution and its regulatory evolution.
    Hoffman DE
    Drake Law Rev; 1988-1989; 38(3):471-550. PubMed ID: 16086466
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends in biotechnology and biosafety in Brazil.
    Mendonça-Hagler L; Souza L; Aleixo L; Oda L
    Environ Biosafety Res; 2008; 7(3):115-21. PubMed ID: 19031659
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotech's defining moments.
    Miller HI
    Trends Biotechnol; 2007 Feb; 25(2):56-9. PubMed ID: 17173993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orphans at the window.
    Nat Biotechnol; 2004 Sep; 22(9):1055. PubMed ID: 15340451
    [No Abstract]   [Full Text] [Related]  

  • 17. No Munich on GM crops.
    Malvoisin P; Grausz JD
    Nat Biotechnol; 2004 Dec; 22(12):1501; discussion 1501. PubMed ID: 15583648
    [No Abstract]   [Full Text] [Related]  

  • 18. Chinese agribiotech: Against the grain.
    Macilwain C
    Nature; 2003 Mar; 422(6928):111-2. PubMed ID: 12634752
    [No Abstract]   [Full Text] [Related]  

  • 19. GM confusion in Brazil.
    Bonalume Neto R
    Nat Biotechnol; 2003 Nov; 21(11):1257-8. PubMed ID: 14595342
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: a call for ethical regulation of genetically created organisms (GCOs) beyond GMOs.
    Lee SY
    Biotechnol J; 2010 Aug; 5(8):791. PubMed ID: 20672287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.